// App-Quantinova.ai

AB084 : The clinical and therapeutic drug monitoring of oral and intravenous busulfan in patients with acute leukemia that underwent to stem cell transplantation with a test dose of busulfan

Researchers

Presenter

  • I. Esteves

Principal Investigators

  • J. Fernandes

  • A. Ribeiro

  • J. C. Barros

  • V. Colturato

  • N. Hamerschlak

  • F. Kerbauy

  • F. Santos

  • G. Perini

  • R. Helman

  • C. Castro

  • V. Mattos

  • A. Kondo

  • A. Seber

  • J. S. Oliveira

Medical Centers

  • Disciplina de Hematologia e Hemoterapia - Universidade Federal de Sao Paulo,

  • Hospital Amaral Carvalho, Jau, Brazil

  • Grupo de Apoio ao Adolescente e Crianca com Cncer - GRAAC,

  • Hospital Brigadeiro, Sao Paulo,

  • Hematology and Stem Cell Transplantation, Hospital Israelita Albert Einstein,

Locations

  • Brazil

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

  • Acute Leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Busulfan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved